Related Experiment Video
Updated: Jun 10, 2026

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
S-phase lengthening induced by p16(INK4a) overexpression in malignant cells with wild-type pRb and p53
Wei Wen Chien1, Carine Domenech, Régine Catallo
1Université Claude Bernard Lyon 1, CNRS UMR 5239, ENS-HCL, Faculté de Médecine, Pierre-Bénite, France.
Abstract:
The p16(INK4a) protein is considered to regulate the cell cycle progression mainly by inhibiting cyclin-dependent kinases (CDKs) 4 and 6 activity and leading to an arrest in G(0)/G(1). Here, we report that ectopic expression of p16(INK4a) in three p16-/pRb(Wt)/p53(Wt) human cancer cell lines MCF7, U2OS and U87 induces S-phase lengthening along with G(1) accumulation. S-phase lengthening is suggested by the discrepancy between the unchanged or even increased percentage of cells in S phase found by flow cytometry DNA content analysis and the drop of BrdU labelling, and demonstrated by IdU/BrdU double labelling. p16(INK4a) induces a profound decrease in the CDK4/6-mediated pRb phosphorylation on Ser-807/811, a downregulation of CDK2 and CDK1 protein expression independently of G(1) accumulation, and a decrease in Thr/Pro phosphorylation in part carried out by CDKs. In MCF7 cells, overexpression of the p16 G101W mutant, which is unable to inhibit CDK4/6 kinase activity and shows a modified subcellular localization, does not provoke the S-phase lengthening and the inhibition of Ser807/811-pRB and of Thr/Pro phosphorylation as wild-type p16(INK4a) does. Our results demonstrate that p16(INK4a) induces a S-phase lengthening independently of cellular origin. The CDK4/6 kinase activity inhibition together with the reduced expression of CDK2 and CDK1 acting downstream of G(1) phase may prevent cells from any possible kinasic compensatory mechanisms, and thus lead to a cell cycle progression inhibition.
Insights
The protein p16 INK4a, when overexpressed, lengthens S-phase and causes G1 accumulation in cancer cells. This cell cycle regulation occurs independently of cell type and involves inhibiting cyclin-dependent kinases (CDKs) 4 and 6.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- The p16(INK4a) protein typically inhibits cyclin-dependent kinases (CDKs) 4 and 6, arresting the cell cycle at G(0)/G(1).
- Understanding p16(INK4a)'s precise role in cell cycle regulation is crucial for cancer therapy development.
Purpose of the Study:
- To investigate the effects of ectopic p16(INK4a) expression on cell cycle progression in human cancer cell lines.
- To elucidate the molecular mechanisms underlying p16(INK4a)-induced cell cycle arrest.
Main Methods:
- Ectopic expression of p16(INK4a) in MCF7, U2OS, and U87 cancer cell lines.
- Flow cytometry for DNA content analysis and BrdU labeling assays.
- IdU/BrdU double labeling and Western blotting to assess protein levels and phosphorylation.
Main Results:
- Ectopic p16(INK4a) expression induced S-phase lengthening and G(1) accumulation across different cancer cell lines.
- p16(INK4a) significantly decreased pRb phosphorylation at Ser-807/811, downregulated CDK2 and CDK1 expression, and reduced Thr/Pro phosphorylation.
- A non-functional p16 mutant failed to induce S-phase lengthening or inhibit key phosphorylation events, confirming the role of CDK4/6 inhibition.
Conclusions:
- p16(INK4a) induces S-phase lengthening and cell cycle arrest independently of cellular origin.
- The mechanism involves inhibiting CDK4/6 activity and downregulating CDK2/CDK1, preventing compensatory kinase activity and halting cell cycle progression.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Inhibition of Cdk Activity
Restarting Stalled Replication Forks

